Cough Remedies Market Report 2025

This Cough Remedies market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The cough remedies market size has grown strongly in recent years. It will grow from $11.06 billion in 2024 to $12.04 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising government healthcare expenditure, growing awareness of natural cough remedies, increased vehicle emissions.

The cough remedies market size is expected to see strong growth in the next few years. It will grow to $16.76 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising prevalence of respiratory diseases, growing geriatric population, innovation in cough treatments, high demand for OTC products, increasing air pollution, growing awareness of self-care. Major trends in the forecast period include investments, company partnerships, ozenge and candy innovations.

The increasing prevalence of respiratory diseases is expected to drive the growth of the cough remedies market in the coming years. Respiratory diseases encompass a wide range of conditions that affect the organs and tissues responsible for breathing and gas exchange. The rise in respiratory diseases can be attributed to factors such as greater exposure to environmental pollutants, overcrowded living conditions, and increased smoke emissions from vehicles. Cough remedies, such as expectorants, help thin mucus in the airways, making it easier for patients to clear their lungs through coughing, thereby relieving discomfort and promoting healing, particularly for those with sore throats or irritated airways. For example, in July 2024, the American Lung Association, a US-based voluntary health organization, reported that the percentage of the US population diagnosed with asthma increased from 12.9% in 2021 to 13.5% in 2022. Therefore, the rising incidence of respiratory diseases is driving the demand for cough remedies.

The increasing prevalence of respiratory diseases is expected to drive the growth of the cough remedies market in the coming years. Respiratory diseases encompass a wide range of conditions that affect the organs and tissues responsible for breathing and gas exchange. The rise in respiratory diseases can be attributed to factors such as greater exposure to environmental pollutants, overcrowded living conditions, and increased smoke emissions from vehicles. Cough remedies, such as expectorants, help thin mucus in the airways, making it easier for patients to clear their lungs through coughing, thereby relieving discomfort and promoting healing, particularly for those with sore throats or irritated airways. For example, in July 2024, the American Lung Association, a US-based voluntary health organization, reported that the percentage of the US population diagnosed with asthma increased from 12.9% in 2021 to 13.5% in 2022. Therefore, the rising incidence of respiratory diseases is driving the demand for cough remedies.

In June 2023, GSK plc, a UK-based pharmaceutical company, acquired BELLUS Health Inc. for an undisclosed sum. This acquisition bolsters GSK's portfolio of specialty medicines and strengthens its expertise in respiratory therapies with BELLUS's promising P2X3 antagonist, currently in phase III development for the first-line treatment of adult patients with refractory chronic cough (RCC). BELLUS Health Inc. is a Canada-based company specializing in novel therapeutics for chronic cough treatment.

Major companies operating in the cough remedies market are Pfizer Inc., The Procter & Gamble Company (P&G), Johnson & Johnson Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Reckitt Benckiser Group, Perrigo Lab India Private Limited, Prestige Brands Holdings Inc., Hyland's Inc., Boiron, Chattem Chemicals Inc., Tris Pharma Inc., Mayne Pharma Inc., Zarbee's Inc., Genexa Inc.

North America was the largest region in the cough remedies market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cough remedies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cough remedies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cough remedies are treatments or methods used to alleviate symptoms associated with coughing, such as irritation, inflammation, or congestion in the respiratory tract. These remedies aim to provide relief from common respiratory issues, reducing the urge to cough and including expectorants to help expel mucus from the airways.

The main product types of cough remedies include expectorants, antihistamines, bronchodilators, decongestants, and antibiotics. Expectorants are medications or natural ingredients that help clear mucus from a person’s airways. The various dosage forms include oral syrups, tablets or pills, nasal drops, and lozenges. These remedies are used by various age groups, including pediatric and adult populations, and are distributed through various channels such as retail pharmacies, hospital pharmacies, and others.

The cough remedies market research report is one of a series of new reports that provides cough remedies market statistics, including cough remedies industry global market size, regional shares, competitors with a cough remedies market share, detailed cough remedies market segments, market trends and opportunities, and any further data you may need to thrive in the cough remedies industry. This cough remedies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cough remedies market consists of sales of natural remedy products, cough suppressants, and over-the-counter remedies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.